Register now for the upcoming Venture Match: LifeScienceTN. The event will be held November 4th from 7:30 - 9:30AM CT at Innovation Park, located at 393 Nichol Mill Lane in Franklin, TN.
Venture Match's intent is to host opportunities for meaningful dialogue with some of our top innovators, to explore market interest in current research, and to match entrepreneurs and industry with inventors and their technologies. Commercialization of technology is a contact sport - the more opportunities to connect people and engage them in conversation, the better for our chances for a match. Programs like these can help all of us build our networks and encourage collaborative, innovative thinking.
Light breakfast & coffee will be provided.
3D Operations, Inc. (3D Ops) is a healthcare service company focused on enhancing patient outcomes by greatly improving pre-surgical planning. The company converts MRI and CT Scan images into 3D printable data, then prints 3D models of patient-specific anatomy for pre-surgical planning. The surgeons can hold, examine, plan and even practice on the patient’s own modeled anatomy prior to surgery or other procedures.
Flow MedTech is an early-stage medical device startup and a Health Wildcatters accelerator portfolio company. The technology is focused on preventing strokes in patients with atrial fibrillation by targeting the left atrial appendage (LAA). The LAA is known to be a breeding ground for clot formation, and 90% of clots in the brain have been traced to the LAA. The patent-pending technology, developed by Georgia Tech biomedical engineering alumni, prevents clot formation by blocking blood flow into the LAA and thus reducing the risk of strokes. The development of this device is supported by cardiologists from the Emory School of Medicine as well as key opinion leader, Dr. Horst Sievert.
SimPath combines state-of-the-art DNA synthesis and assembly methods to construct multiple variations of a pathway for researchers quicker and cheaper than present day services. The company’s advantage is its assembly method, which is ten times more efficient than today’s methods and 100% flexible, allowing one-time DNA synthesis for use in any variation of a pathway. In addition, SimPath provides a user-friendly, intuitive web-interface for designing pathways, an element our competitors lack.
SOMAVAC Medical is creating a wearable, ultra-low profile, low-power suction device for removal of post-surgical fluid. The device is easy to conceal and operate and has a disposable reservoir, with graduations for measurements, that can be easily attached or detached. The SOMAVAC's solution is unique in the post-surgical fluid management space in that it provides better performance as well as much-needed improvements in patient experience with a potential to reduce the risk of complications and re-treatments.
Surgiorithm helps surgeons increase revenue by capturing patient opportunities. The company has focused its first product launch for ophthalmologists. Cataract surgeons leave $700M annually on the table by not recognizing patients who are ready to upgrade to high-tech lenses cataract surgery to both remove the cataract and enhance visual acuity. Using preference-based selling, and iPad based technology, our product guides patients and surgeons to select between equally viable options based on patient objectives. Since July 2016, seven surgeons and 450 patients in Tennessee, Alabama and Georgia have been using the technology with a 97% completion rate.